Publicaciones (53) Publicaciones de LUIS ANDRÉS GONZÁLEZ BAYÓN

2024

  1. Ibero-American Consensus for the Management of Peritoneal Sarcomatosis: Updated Review and Clinical Recommendations

    Cancers, Vol. 16, Núm. 15

2023

  1. Appendiceal Mucinous Neoplasms: From Clinic to Pathology and Prognosis

    Cancers, Vol. 15, Núm. 13

  2. External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification

    European Journal of Surgical Oncology, Vol. 49, Núm. 8, pp. 1481-1488

  3. Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement

    Clinical and Translational Oncology, Vol. 25, Núm. 12, pp. 3378-3394

  4. Which classification system defines best prognosis of mucinous neoplasms of the appendix with peritoneal dissemination: TNM vs PSOGI?

    Journal of clinical pathology, Vol. 76, Núm. 4, pp. 266-273

2022

  1. ASO Author Reflections: Predicting Prognosis in Patients with Pseudomyxoma

    Annals of Surgical Oncology

  2. An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    World Journal of Surgery, Vol. 46, Núm. 6, pp. 1336-1343

  3. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases

    BMC Cancer, Vol. 22, Núm. 1

  4. Multimodal approach of leiomyosarcoma of the inferior vena cava: case report and literature review of main points of controversy

    Chirurgia (Turin), Vol. 35, Núm. 5, pp. 291-298

  5. Validation of a Nomogram to Predict Recurrence in Patients with Mucinous Neoplasms of the Appendix with Peritoneal Dissemination After Cytoreductive Surgery and HIPEC

    Annals of Surgical Oncology, Vol. 29, Núm. 12, pp. 7553-7563

2021

  1. Defining stage in mucinous tumours of the appendix with peritoneal dissemination: the importance of grading terminology: systematic review

    BJS open, Vol. 5, Núm. 4

  2. Effect of cilastatin on cisplatin-induced nephrotoxicity in patients undergoing hyperthermic intraperitoneal chemotherapy

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-17

2020

  1. ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in locally recurrent rectal cancer

    Clinical and Translational Radiation Oncology, Vol. 24, pp. 41-48

  2. Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP)

    Clinical and Translational Oncology, Vol. 22, Núm. 1, pp. 130-136

2018

  1. Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey

    European Journal of Surgical Oncology, Vol. 44, Núm. 2, pp. 228-236

  2. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups

    European Journal of Surgical Oncology, Vol. 44, Núm. 9, pp. 1378-1383

  3. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study

    European Journal of Surgical Oncology, Vol. 44, Núm. 11, pp. 1786-1792

  4. Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients

    Annals of Surgical Oncology, Vol. 25, Núm. 4, pp. 1094-1100

2017

  1. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1388-1392

2016

  1. Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study

    Surgical Oncology, Vol. 25, Núm. 2, pp. 111-116